- Home
- NBR vs ETON Comparison
NBR vs ETON Comparison
Compare NBR & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NBR | ETON |
|---|---|---|
| Founded | 1952 | 2017 |
| Country | Bermuda | United States |
| Employees | 13900 | 44 |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | NBR | ETON |
|---|---|---|
| Price | $81.59 | $44.57 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $75.00 | $39.33 |
| AVG Volume (30 Days) | 246.5K | ★ 524.3K |
| Earning Date | 04-28-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $79,950,000.00 |
| Revenue This Year | $3.65 | $40.90 |
| Revenue Next Year | $4.88 | $47.23 |
| P/E Ratio | ★ $4.33 | $923.60 |
| Revenue Growth | N/A | ★ 104.94 |
| 52 Week Low | $31.10 | $14.27 |
| 52 Week High | $112.90 | $50.18 |
Technical Indicators
Market Signals| Indicator | NBR | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 49.70 | 63.97 |
| Support Level | $75.44 | $15.77 |
| Resistance Level | $85.15 | $50.18 |
| Average True Range (ATR) | 3.97 | 2.56 |
| MACD | 0.42 | -0.08 |
| Stochastic Oscillator | 62.14 | 59.75 |
Price Performance
Historical ComparisonAbout NBR Nabors Industries Ltd.
Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and technologies. The company has four reportable segments: U.S. Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.